Categories: HealthcareNews

Nikon releases the ECLIPSE Ti2-I motorized inverted microscope for reproductive medicine for greater efficiency and more accurate performance in ICSI/IMSI workflow infertility treatments

MELVILLE, N.Y., July 8, 2025 /PRNewswire/ — Nikon Instruments Inc. (Nikon) announced the launch of the ECLIPSE Ti2-I Motorized Inverted Microscope for ICSI1/IMSI2, specifically designed for use in micro-insemination (IVF). This new microscope system is designed to improve efficiency and speed by reducing the steps required for operation in IVF procedures by approximately 75 percent.

In the United States, the workload of embryology and infertility treatment regimens continues to rise in response to falling fertility and birth rates. While the workload of embryologists has increased with the rise in the number of infertility treatments, improved accuracy in their work remains a critical factor. The new ECLIPSE Ti2-I microscope is specifically designed to aid in the efficiency as this work becomes ever more vital.

Main Features

  1. Up to 75% reduction of the steps required for microscope operation for improved efficiency of the micro-insemination workflow.

    The ECLIPSE Ti2-I microscope is equipped with multiple observation settings for each process in the IVF procedure which are consolidated into simple controls within easy reach at the front of the microscope. This new capability allows switching of the observation modes with a single touch, improving the efficiency of micro-insemination workflows where observation modes are frequently changed.

  2. User-friendly design to help reduce errors.

    The touch screen enables users to easily review the currently selected observation method and provides status and error messages in case a user needs to be alerted.

  3. Bright and clear observation with Nikon’s unique optical technology

    Eggs and sperm can be observed clearly by improving the brightness of the field of view with Nikon’s unique optical technology. Eggs and sperm can be observed clearly by improving the brightness of the field of view with Nikon’s unique optical technology. Traditionally observing the spindle within an egg can be difficult, but Nikon’s optical technology in the ECLIPSE Ti2-I microscope allows observation of the hard to see spindle in contrasting colors regardless of the orientation of the egg. Nikon’s spindle observation system helps avoid damaging the spindle of the egg during sperm injection and may be used to determine if the oocyte is mature enough for injection.

1 Intracytoplasmic Sperm Injection: Method to inject sperm directly into the egg while observing with a microscope
2 Intracytoplasmic Morphologically Selected Sperm Injection: Method to select sperm used for ICSI using a high magnification microscope while evaluating and observing the morphology and structure of sperm in more detail
3 Photo with the manipulator from Narishige Lifemed Co., Ltd. installed

View original content to download multimedia:https://www.prnewswire.com/news-releases/nikon-releases-the-eclipse-ti2-i-motorized-inverted-microscope-for-reproductive-medicine-for-greater-efficiency-and-more-accurate-performance-in-icsiimsi-workflow-infertility-treatments-302499356.html

SOURCE Nikon Instruments Inc.

Staff

Recent Posts

Obesity Medicine Association Releases Position Statement: A New Era for Medicare & Medicaid Obesity Medication Coverage

Centennial, Colorado--(Newsfile Corp. - December 24, 2025) - The Obesity Medicine Association (OMA) released its…

52 minutes ago

pcc Practice Builder™ Emerges as a Growth Engine for Medical Practices in 2026

METUCHIN, N.J., Dec. 23, 2025 /PRNewswire/ -- As 2026 approaches, podiatrists, chiropractors, and dentists are…

15 hours ago

Therap Services Enhances Individual Plan Workflows to Boost Efficiency and Improve User Experience

TORRINGTON, Conn., Dec. 23, 2025 /PRNewswire/ -- Therap Services, the national leader in HIPAA-compliant electronic documentation…

15 hours ago

Bausch Health Announces Final Results and Expiration of Exchange Offers

LAVAL, QC / ACCESS Newswire / December 23, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC)…

15 hours ago

CASI Pharmaceuticals Receives Extension from Nasdaq to Meet Listing Requirements

SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 23, 2025 / CASI Pharmaceuticals, Inc.…

15 hours ago

A Year of Purpose and Progress: Dr. Christina Rahm Celebrates Global Growth, Scientific Breakthroughs, and International Honors

Franklin, Tennessee--(Newsfile Corp. - December 23, 2025) - From global stages and scientific breakthroughs to…

21 hours ago